National Perinatal Association Guidance for Palivizumab Prophylaxis
Increases Coverage to that Provided by the FDA Indication
Abstract
This editorial is an invited response to “Adherence to the 2014
American Academy of Pediatrics Palivizumab Prophylaxis Recommendations”